D-Index & Metrics Best Publications
Research.com 2022 Best Female Scientist Award Badge

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 113 Citations 42,244 419 World Ranking 2144 National Ranking 1255
Best female scientists D-index 113 Citations 43,054 585 World Ranking 453 National Ranking 279

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Female Scientist Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Cancer
  • Internal medicine
  • Surgery

Susan M. Chang focuses on Glioma, Internal medicine, Surgery, Oncology and Pathology. Her study in Glioma is interdisciplinary in nature, drawing from both Brain tumor, Central nervous system disease and Extent of resection. Her Central nervous system disease research incorporates elements of Biopsy and Nuclear medicine.

Her Surgery research includes elements of Clinical trial and Hazard ratio. Her Oncology study combines topics in areas such as Epidermal growth factor receptor, Survival rate, Radiation therapy, Temozolomide and Rash. Her studies in Pathology integrate themes in fields like Tumor progression and Blood volume.

Her most cited work include:

  • Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group (2465 citations)
  • Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors (1025 citations)
  • Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas (926 citations)

What are the main themes of her work throughout her whole career to date?

Her scientific interests lie mostly in Glioma, Internal medicine, Oncology, Radiation therapy and Surgery. The concepts of her Glioma study are interwoven with issues in Brain tumor, Pathology and Magnetic resonance imaging. Her research in Magnetic resonance imaging intersects with topics in Tumor progression, Nuclear medicine and Medical imaging.

Her studies in Temozolomide, Clinical trial, Phases of clinical research, Chemotherapy and Progression-free survival are all subfields of Internal medicine research. Her studies deal with areas such as Medical physics, Neurologic Oncology and Intensive care medicine as well as Clinical trial. Her Oncology study deals with Glioblastoma intersecting with Newly diagnosed.

She most often published in these fields:

  • Glioma (35.65%)
  • Internal medicine (32.52%)
  • Oncology (28.70%)

What were the highlights of her more recent work (between 2018-2021)?

  • Glioma (35.65%)
  • Internal medicine (32.52%)
  • Cancer research (10.26%)

In recent papers she was focusing on the following fields of study:

The scientist’s investigation covers issues in Glioma, Internal medicine, Cancer research, Clinical trial and Brain tumor. Her study in the field of Temozolomide is also linked to topics like Patient-reported outcome. Her Internal medicine research includes themes of Anticonvulsant and Oncology.

Her research integrates issues of Glioblastoma and Chemotherapy in her study of Oncology. In Clinical trial, Susan M. Chang works on issues like Intensive care medicine, which are connected to Response assessment and Disease. While the research belongs to areas of Brain tumor, Susan M. Chang spends her time largely on the problem of Cancer, intersecting her research to questions surrounding Neurologic Oncology.

Between 2018 and 2021, her most popular works were:

  • Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions (100 citations)
  • The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation. (87 citations)
  • Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. (86 citations)

In her most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

Her main research concerns Glioma, Brain tumor, Intensive care medicine, Clinical trial and Cancer research. Her Temozolomide study in the realm of Glioma interacts with subjects such as World health. Her Brain tumor research incorporates themes from Cancer, Internal medicine, Oncology and Magnetic resonance imaging, Radiology.

In the field of Internal medicine, her study on Interquartile range and Tumor progression overlaps with subjects such as Window of opportunity. The various areas that Susan M. Chang examines in her Oncology study include Retrospective cohort study, Molecular pathogenesis and Glioblastoma. Susan M. Chang has included themes like Drug action and Pharmacodynamics in her Clinical trial study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

Patrick Y. Wen;David R. Macdonald;David A. Reardon;Timothy F. Cloughesy.
Journal of Clinical Oncology (2010)

2941 Citations

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

Jeanette E Eckel-Passow;Daniel H Lachance;Annette M. Molinaro;Kyle M. Walsh.
The New England Journal of Medicine (2015)

1274 Citations

Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas

Justin S. Smith;Edward F. Chang;Kathleen R. Lamborn;Susan M. Chang.
Journal of Clinical Oncology (2008)

1148 Citations

Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma

Brett E. Johnson;Tali Mazor;Chibo Hong;Michael Barnes.
Science (2014)

1040 Citations

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.

Edward R. Laws Jr.;Ian F. Parney;Wei Huang;Frederick A. Anderson Jr..
Journal of Neurosurgery (2003)

784 Citations

Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis

Kathleen R. Lamborn;Susan M. Chang;Michael D. Prados.
Neuro-oncology (2004)

540 Citations

Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

Penny K Sneed;Kathleen R Lamborn;Julie M Forstner;Michael W McDermott.
International Journal of Radiation Oncology Biology Physics (1999)

520 Citations

Variants in the CDKN2B and RTEL1 regions are associated with high grade glioma susceptibility

Margaret Wrensch;Robert B. Jenkins;Jeffrey S. Chang;Ru Fang Yeh.
Nature Genetics (2009)

499 Citations

Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens.

Chris Dowling;Andrew W. Bollen;Susan M. Noworolski;Michael W. McDermott.
American Journal of Neuroradiology (2001)

498 Citations

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.

Penny K. Sneed;Paul R. Stauffer;Michael W. McDermott;Chris J. Diederich.
International Journal of Radiation Oncology Biology Physics (1996)

480 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Susan M. Chang

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 260

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 190

David A. Reardon

David A. Reardon

Harvard University

Publications: 180

Michael Weller

Michael Weller

University of Zurich

Publications: 169

Timothy F. Cloughesy

Timothy F. Cloughesy

University of California, Los Angeles

Publications: 150

Hugues Duffau

Hugues Duffau

University of Montpellier

Publications: 141

Mitchel S. Berger

Mitchel S. Berger

University of California, San Francisco

Publications: 136

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 104

Mark R. Gilbert

Mark R. Gilbert

The University of Texas MD Anderson Cancer Center

Publications: 104

Kenneth D. Aldape

Kenneth D. Aldape

Princess Margaret Cancer Centre

Publications: 103

Tracy T. Batchelor

Tracy T. Batchelor

Brigham and Women's Hospital

Publications: 100

Arjun Sahgal

Arjun Sahgal

Sunnybrook Health Science Centre

Publications: 89

John H. Sampson

John H. Sampson

Duke University

Publications: 89

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 88

Keith L. Ligon

Keith L. Ligon

Harvard University

Publications: 78

Michael A. Vogelbaum

Michael A. Vogelbaum

Cleveland Clinic

Publications: 77

Something went wrong. Please try again later.